Literature DB >> 2706361

Conditions for quantitation of dolichyl phosphate, dolichol, ubiquinone and cholesterol by HPLC.

P G Elmberger1, I Eggens, G Dallner.   

Abstract

Conditions for the isolation and quantitation of dolichyl phosphate, dolichol, cholesterol, and ubiquinone by reversed phase high performance liquid chromatography were investigated. A simple and fast sample preparation procedure using prepacked mini columns was employed. The UV spectra of the fractions obtained were examined and, in the case of dolichol compounds, the maximum absorbance around 205 nm was shown to be linearly dependent on the number of double bonds present in the isoprenolog. The analytical procedure described shows a very broad range of linearity (five orders of magnitude) and detects single dolichyl phosphate isoprenologs in amounts as small as 0.1 ng. The lowest overall recovery, that for dolichyl phosphate, is 77%. Use of isoprenolog 23 and ergosterol as internal standards reduced the variation in the method to 2.5, 4.0 and 5.5% for cholesterol, dolichyl phosphate and dolichol, respectively. The method described was employed to study the lipid composition of rat organs and biological variations in these compositions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2706361     DOI: 10.1002/bmc.1130030106

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  7 in total

1.  Improvement of dolichol-linked oligosaccharide biosynthesis by the squalene synthase inhibitor zaragozic acid.

Authors:  Micha A Haeuptle; Michael Welti; Heinz Troxler; Andreas J Hülsmeier; Timo Imbach; Thierry Hennet
Journal:  J Biol Chem       Date:  2010-12-23       Impact factor: 5.157

2.  MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If.

Authors:  B Schenk; T Imbach; C G Frank; C E Grubenmann; G V Raymond; H Hurvitz; I Korn-Lubetzki; S Revel-Vik; A Raas-Rotschild; A S Luder; J Jaeken; E G Berger; G Matthijs; T Hennet; M Aebi
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

3.  Discharge of newly-synthesized dolichol and ubiquinone with lipoproteins to rat liver perfusate and to the bile.

Authors:  P G Elmberger; A Kalén; U T Brunk; G Dallner
Journal:  Lipids       Date:  1989-11       Impact factor: 1.880

4.  Studies on the biosynthesis of polyisoprenols, cholesterol and ubiquinone in highly differentiated human hepatomas.

Authors:  I Eggens; T J Ekström; F Aberg
Journal:  J Exp Pathol (Oxford)       Date:  1990-04

5.  Effect of dietary fat on rat liver microsomal and mitochondrial/lysosomal dolichol, phospholipid and cholesterol.

Authors:  A Jakobsson-Borin; O Tollbom; G Dallner
Journal:  Lipids       Date:  1991-11       Impact factor: 1.880

6.  Uptake and metabolism of dolichol and cholesterol in perfused rat liver.

Authors:  A Kalén; M Söderberg; P G Elmberger; G Dallner
Journal:  Lipids       Date:  1990-02       Impact factor: 1.880

7.  Nonmembrane associated dolichol in rat liver.

Authors:  P Löw; E Peterson; C Edlund; U Brunk; E L Appelkvist
Journal:  Lipids       Date:  1992-01       Impact factor: 1.880

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.